APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over the Counter (OTC) Drugs & Dietary Supplements

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Over the Counter (OTC) Drugs & Dietary Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchOver the Counter (OTC) Drugs & Dietary Supplements Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Over the Counter (OTC) Drugs & Dietary Supplements Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Over the Counter (OTC) Drugs & Dietary Supplements market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Over the Counter (OTC) Drugs & Dietary Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Over the Counter (OTC) Drugs & Dietary Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Over the Counter (OTC) Drugs & Dietary Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Over the Counter (OTC) Drugs & Dietary Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Over the Counter (OTC) Drugs & Dietary Supplements include Sanofi S.A, Johnson & Johnson, Novartis International AG, Merck & Co., Inc., Roche Holding AG, Pfizer Inc., GlaxoSmithKline plc., Bayer Healthcare AG and AbbVie Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Over the Counter (OTC) Drugs & Dietary Supplements market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Over the Counter (OTC) Drugs & Dietary Supplements and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Over the Counter (OTC) Drugs & Dietary Supplements revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Over the Counter (OTC) Drugs & Dietary Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Company

Sanofi S.A

Johnson & Johnson

Novartis International AG

Merck & Co., Inc.

Roche Holding AG

Pfizer Inc.

GlaxoSmithKline plc.

Bayer Healthcare AG

AbbVie Inc.

AstraZeneca plc.

The Colgate-Palmolive Company

Reckitt Benckiser Plc.

Gilead Sciences

Bausch & Lomb

Alliance Healthcare

Allergan, Plc.

Alkalon A/S

Alfresa Pharma Corporation

Alcon Inc.

Alacer Corp.

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Type

Cough, Cold, and Flu Products

Mineral Supplements

Dermatological Products

Vitamin Supplements

Ophthalmic Products

Analgesic & Pain Relievers

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Application

Retail Pharmacies

Online Pharmacy

Hospital Pharmacies

Others

Over the Counter (OTC) Drugs & Dietary Supplements Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over the Counter (OTC) Drugs & Dietary Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over the Counter (OTC) Drugs & Dietary Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over the Counter (OTC) Drugs & Dietary Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Over the Counter (OTC) Drugs & Dietary Supplements in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Over the Counter (OTC) Drugs & Dietary Supplements industry.

Chapter 3: Detailed analysis of Over the Counter (OTC) Drugs & Dietary Supplements companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Over the Counter (OTC) Drugs & Dietary Supplementsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cough, Cold, and Flu Products Table 3. Key Players of Mineral Supplements Table 4. Key Players of Dermatological Products Table 3. Key Players of Vitamin Supplements Table 4. Key Players of Ophthalmic Products Table 5. Key Players of Analgesic & Pain Relievers Table 6. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Retail Pharmacies Table 8. Key Players of Online Pharmacy Table 9. Key Players of Hospital Pharmacies Table 10. Key Players of Others Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2021-2026) Table 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2027-2032) Table 16. Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends Table 17. Over the Counter (OTC) Drugs & Dietary Supplements Industry Drivers Table 18. Over the Counter (OTC) Drugs & Dietary Supplements Industry Opportunities and Challenges Table 19. Over the Counter (OTC) Drugs & Dietary Supplements Industry Restraints Table 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Company (2021-2026) Table 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Key Company Head Office and Area Served Table 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Company, Product Type & Application Table 25. Global Over the Counter (OTC) Drugs & Dietary Supplements Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2021-2026) Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2027-2032) Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2021-2026) Table 37. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2027-2032) Table 38. Sanofi S.A Company Information Table 39. Sanofi S.A Business Overview Table 40. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 42. Sanofi S.A Recent Development Table 43. Johnson & Johnson Company Information Table 44. Johnson & Johnson Business Overview Table 45. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 47. Johnson & Johnson Recent Development Table 48. Novartis International AG Company Information Table 49. Novartis International AG Business Overview Table 50. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 52. Novartis International AG Recent Development Table 53. Merck & Co., Inc. Company Information Table 54. Merck & Co., Inc. Business Overview Table 55. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 57. Merck & Co., Inc. Recent Development Table 58. Roche Holding AG Company Information Table 59. Roche Holding AG Business Overview Table 60. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 62. Roche Holding AG Recent Development Table 63. Pfizer Inc. Company Information Table 64. Pfizer Inc. Business Overview Table 65. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 67. Pfizer Inc. Recent Development Table 68. GlaxoSmithKline plc. Company Information Table 69. GlaxoSmithKline plc. Business Overview Table 70. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 72. GlaxoSmithKline plc. Recent Development Table 73. Bayer Healthcare AG Company Information Table 74. Bayer Healthcare AG Business Overview Table 75. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 77. Bayer Healthcare AG Recent Development Table 78. AbbVie Inc. Company Information Table 79. AbbVie Inc. Business Overview Table 80. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 82. AbbVie Inc. Recent Development Table 83. AstraZeneca plc. Company Information Table 84. AstraZeneca plc. Business Overview Table 85. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 87. AstraZeneca plc. Recent Development Table 88. The Colgate-Palmolive Company Company Information Table 89. The Colgate-Palmolive Company Business Overview Table 90. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 92. The Colgate-Palmolive Company Recent Development Table 93. Reckitt Benckiser Plc. Company Information Table 94. Reckitt Benckiser Plc. Business Overview Table 95. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 97. Reckitt Benckiser Plc. Recent Development Table 98. Gilead Sciences Company Information Table 99. Gilead Sciences Business Overview Table 100. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 102. Gilead Sciences Recent Development Table 103. Bausch & Lomb Company Information Table 104. Bausch & Lomb Business Overview Table 105. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 107. Bausch & Lomb Recent Development Table 108. Alliance Healthcare Company Information Table 109. Alliance Healthcare Business Overview Table 110. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 111. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 112. Alliance Healthcare Recent Development Table 113. Allergan, Plc. Company Information Table 114. Allergan, Plc. Business Overview Table 115. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 116. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 117. Allergan, Plc. Recent Development Table 118. Alkalon A/S Company Information Table 119. Alkalon A/S Business Overview Table 120. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 121. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 122. Alkalon A/S Recent Development Table 123. Alfresa Pharma Corporation Company Information Table 124. Alfresa Pharma Corporation Business Overview Table 125. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 126. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 127. Alfresa Pharma Corporation Recent Development Table 128. Alcon Inc. Company Information Table 129. Alcon Inc. Business Overview Table 130. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 131. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 132. Alcon Inc. Recent Development Table 133. Alacer Corp. Company Information Table 134. Alacer Corp. Business Overview Table 135. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026) Table 136. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio Table 137. Alacer Corp. Recent Development Table 138. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026) & (US$ Million) Table 139. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032) & (US$ Million) Table 140. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026) & (US$ Million) Table 141. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032) & (US$ Million) Table 142. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) Table 144. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032) Table 145. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026) & (US$ Million) Table 146. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032) & (US$ Million) Table 147. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026) & (US$ Million) Table 148. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032) & (US$ Million) Table 149. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) Table 151. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032) Table 152. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026) & (US$ Million) Table 153. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032) & (US$ Million) Table 154. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026) & (US$ Million) Table 155. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032) & (US$ Million) Table 156. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026) & (US$ Million) Table 157. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032) & (US$ Million) Table 158. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026) & (US$ Million) Table 159. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032) & (US$ Million) Table 160. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) Table 162. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032) Table 163. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026) & (US$ Million) Table 164. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032) & (US$ Million) Table 165. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026) & (US$ Million) Table 166. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032) & (US$ Million) Table 167. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026) Table 169. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032) Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Over the Counter (OTC) Drugs & Dietary Supplements Product Image Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type: 2025 VS 2032 Figure 4. Cough, Cold, and Flu Products Image Figure 5. Mineral Supplements Image Figure 6. Dermatological Products Image Figure 7. Vitamin Supplements Image Figure 8. Ophthalmic Products Image Figure 9. Analgesic & Pain Relievers Image Figure 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2025 VS 2032 Figure 12. Retail Pharmacies Image Figure 13. Online Pharmacy Image Figure 14. Hospital Pharmacies Image Figure 15. Others Image Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Over the Counter (OTC) Drugs & Dietary Supplements Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2021-2032) Figure 25. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2021-2032) Figure 27. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 28. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2021-2032) Figure 29. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2021-2032) Figure 30. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 31. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 32. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 34. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 35. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2021-2032) Figure 36. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2021-2032) Figure 37. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 38. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 39. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 41. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 42. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 44. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 45. China Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2021-2032) Figure 46. China Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2021-2032) Figure 47. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 48. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2021-2032) Figure 49. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2021-2032) Figure 50. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 51. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 55. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 56. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032) Figure 61. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 66. UAE Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 68. Chile Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Cough, Cold, and Flu Products
  • Mineral Supplements
  • Dermatological Products
  • Vitamin Supplements
  • Ophthalmic Products
  • Analgesic & Pain Relievers
Applications
  • Retail Pharmacies
  • Online Pharmacy
  • Hospital Pharmacies
  • Others
Companies covered
  • Sanofi S.A
  • Johnson & Johnson
  • Novartis International AG
  • Merck & Co., Inc.
  • Roche Holding AG
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Bayer Healthcare AG
  • AbbVie Inc.
  • AstraZeneca plc.
  • The Colgate-Palmolive Company
  • Reckitt Benckiser Plc.
  • Gilead Sciences
  • Bausch & Lomb
  • Alliance Healthcare
  • Allergan, Plc.
  • Alkalon A/S
  • Alfresa Pharma Corporation
  • Alcon Inc.
  • Alacer Corp.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cough, Cold, and Flu Products
  5. 1.2.3 Mineral Supplements
  6. 1.2.4 Dermatological Products
  7. 1.2.5 Vitamin Supplements
  8. 1.2.6 Ophthalmic Products
  9. 1.2.7 Analgesic & Pain Relievers
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Retail Pharmacies
  13. 1.3.3 Online Pharmacy
  14. 1.3.4 Hospital Pharmacies
  15. 1.3.5 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region
  18. 1.5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2021-2026)
  20. 1.5.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
  1. 2.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
  2. 2.2 Over the Counter (OTC) Drugs & Dietary Supplements Industry Drivers
  3. 2.3 Over the Counter (OTC) Drugs & Dietary Supplements Industry Opportunities and Challenges
  4. 2.4 Over the Counter (OTC) Drugs & Dietary Supplements Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Company (2021-2026)
  2. 3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Key Company Head office and Area Served
  4. 3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Company, Product Type & Application
  5. 3.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Over the Counter (OTC) Drugs & Dietary Supplements Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Over the Counter (OTC) Drugs & Dietary Supplements Tier 1, Tier 2, and Tier 3
4 Over the Counter (OTC) Drugs & Dietary Supplements Market by Type
  1. 4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2032)
  3. 4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Type (2021-2032)
5 Over the Counter (OTC) Drugs & Dietary Supplements Market by Application
  1. 5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2032)
  3. 5.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi S.A
  2. 6.1.1 Sanofi S.A Company Information
  3. 6.1.2 Sanofi S.A Business Overview
  4. 6.1.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  6. 6.1.5 Sanofi S.A Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis International AG
  14. 6.3.1 Novartis International AG Company Information
  15. 6.3.2 Novartis International AG Business Overview
  16. 6.3.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  18. 6.3.5 Novartis International AG Recent Developments
  19. 6.4 Merck & Co., Inc.
  20. 6.4.1 Merck & Co., Inc. Company Information
  21. 6.4.2 Merck & Co., Inc. Business Overview
  22. 6.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  24. 6.4.5 Merck & Co., Inc. Recent Developments
  25. 6.5 Roche Holding AG
  26. 6.5.1 Roche Holding AG Company Information
  27. 6.5.2 Roche Holding AG Business Overview
  28. 6.5.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  30. 6.5.5 Roche Holding AG Recent Developments
  31. 6.6 Pfizer Inc.
  32. 6.6.1 Pfizer Inc. Company Information
  33. 6.6.2 Pfizer Inc. Business Overview
  34. 6.6.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  36. 6.6.5 Pfizer Inc. Recent Developments
  37. 6.7 GlaxoSmithKline plc.
  38. 6.7.1 GlaxoSmithKline plc. Company Information
  39. 6.7.2 GlaxoSmithKline plc. Business Overview
  40. 6.7.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  42. 6.7.5 GlaxoSmithKline plc. Recent Developments
  43. 6.8 Bayer Healthcare AG
  44. 6.8.1 Bayer Healthcare AG Company Information
  45. 6.8.2 Bayer Healthcare AG Business Overview
  46. 6.8.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  48. 6.8.5 Bayer Healthcare AG Recent Developments
  49. 6.9 AbbVie Inc.
  50. 6.9.1 AbbVie Inc. Company Information
  51. 6.9.2 AbbVie Inc. Business Overview
  52. 6.9.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  54. 6.9.5 AbbVie Inc. Recent Developments
  55. 6.10 AstraZeneca plc.
  56. 6.10.1 AstraZeneca plc. Company Information
  57. 6.10.2 AstraZeneca plc. Business Overview
  58. 6.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  60. 6.10.5 AstraZeneca plc. Recent Developments
  61. 6.11 The Colgate-Palmolive Company
  62. 6.11.1 The Colgate-Palmolive Company Company Information
  63. 6.11.2 The Colgate-Palmolive Company Business Overview
  64. 6.11.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  66. 6.11.5 The Colgate-Palmolive Company Recent Developments
  67. 6.12 Reckitt Benckiser Plc.
  68. 6.12.1 Reckitt Benckiser Plc. Company Information
  69. 6.12.2 Reckitt Benckiser Plc. Business Overview
  70. 6.12.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  72. 6.12.5 Reckitt Benckiser Plc. Recent Developments
  73. 6.13 Gilead Sciences
  74. 6.13.1 Gilead Sciences Company Information
  75. 6.13.2 Gilead Sciences Business Overview
  76. 6.13.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  78. 6.13.5 Gilead Sciences Recent Developments
  79. 6.14 Bausch & Lomb
  80. 6.14.1 Bausch & Lomb Company Information
  81. 6.14.2 Bausch & Lomb Business Overview
  82. 6.14.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  84. 6.14.5 Bausch & Lomb Recent Developments
  85. 6.15 Alliance Healthcare
  86. 6.15.1 Alliance Healthcare Company Information
  87. 6.15.2 Alliance Healthcare Business Overview
  88. 6.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  90. 6.15.5 Alliance Healthcare Recent Developments
  91. 6.16 Allergan, Plc.
  92. 6.16.1 Allergan, Plc. Company Information
  93. 6.16.2 Allergan, Plc. Business Overview
  94. 6.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  96. 6.16.5 Allergan, Plc. Recent Developments
  97. 6.17 Alkalon A/S
  98. 6.17.1 Alkalon A/S Company Information
  99. 6.17.2 Alkalon A/S Business Overview
  100. 6.17.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  102. 6.17.5 Alkalon A/S Recent Developments
  103. 6.18 Alfresa Pharma Corporation
  104. 6.18.1 Alfresa Pharma Corporation Company Information
  105. 6.18.2 Alfresa Pharma Corporation Business Overview
  106. 6.18.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  108. 6.18.5 Alfresa Pharma Corporation Recent Developments
  109. 6.19 Alcon Inc.
  110. 6.19.1 Alcon Inc. Company Information
  111. 6.19.2 Alcon Inc. Business Overview
  112. 6.19.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  114. 6.19.5 Alcon Inc. Recent Developments
  115. 6.20 Alacer Corp.
  116. 6.20.1 Alacer Corp. Company Information
  117. 6.20.2 Alacer Corp. Business Overview
  118. 6.20.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio
  120. 6.20.5 Alacer Corp. Recent Developments
7 North America
  1. 7.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  2. 7.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
  3. 7.2.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026)
  4. 7.2.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032)
  5. 7.2.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2021-2032)
  6. 7.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
  7. 7.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026)
  8. 7.3.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032)
  9. 7.3.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2021-2032)
  10. 7.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
  11. 7.4.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  13. 7.4.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032)
  14. 7.4.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  2. 8.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
  3. 8.2.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026)
  4. 8.2.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032)
  5. 8.2.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2021-2032)
  6. 8.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
  7. 8.3.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026)
  8. 8.3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032)
  9. 8.3.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2021-2032)
  10. 8.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
  11. 8.4.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  13. 8.4.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032)
  14. 8.4.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  2. 9.2 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
  3. 9.2.1 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026)
  4. 9.2.2 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032)
  5. 9.2.3 China Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2021-2032)
  6. 9.3 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
  7. 9.3.1 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026)
  8. 9.3.2 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032)
  9. 9.3.3 China Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  2. 10.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
  3. 10.2.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026)
  4. 10.2.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032)
  5. 10.2.3 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2021-2032)
  6. 10.3 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
  7. 10.3.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026)
  8. 10.3.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032)
  9. 10.3.3 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2021-2032)
  10. 10.4 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
  11. 10.4.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  13. 10.4.3 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032)
  14. 10.4.4 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst